👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Sean Dulloo
Oncology
English
Hindi
Tamil
7,514+
Patients seen
12
Years in practice
9
Publications
3
Languages spoken
About
Dr Sean Dulloo is a consultant medical oncologist and Honorary Associate Professor. He is current Head of Service for Oncology at the University Hospitals of Leicester NHS Trust. He is also the clinical lead for thoracic oncology. He specialises in managing thoracic cancers, hepato-pancreato-biliary cancers, and neuroendocrine tumours. He has a passion for advancing cancer care, as Dr Dulloo is deeply involved in research and clinical trials, contributing to groundbreaking studies published in high-impact journals, including Nature.
Dr Dulloo completed his basic medical training at the University of Mauritius, followed by an internal medicine residency at the National University Health System, Singapore. He went on to complete his specialist training in Medical Oncology in Leicester. During his training, he carried out a degree in research focusing on Epithelial Mesenchymal Transition in Mesothelioma. He also holds a Master’s degree in Health Economics, Policy and Management from the London School of Economics, reflecting his interest in improving healthcare delivery and accessibility.
As a key figure in oncology research, Dr Dulloo serves as a Chief and Principal Investigator in various international clinical trials including early phase trials. His work focuses on innovative treatments for pleural mesothelioma and lung cancer. He has also presented his work at major conferences, which highlights the importance of precision therapy for patients with limited options. Dr Dulloo strives to combine clinical excellence with compassionate care, ensuring the best possible outcomes for those he treats.
Dr Dulloo completed his basic medical training at the University of Mauritius, followed by an internal medicine residency at the National University Health System, Singapore. He went on to complete his specialist training in Medical Oncology in Leicester. During his training, he carried out a degree in research focusing on Epithelial Mesenchymal Transition in Mesothelioma. He also holds a Master’s degree in Health Economics, Policy and Management from the London School of Economics, reflecting his interest in improving healthcare delivery and accessibility.
As a key figure in oncology research, Dr Dulloo serves as a Chief and Principal Investigator in various international clinical trials including early phase trials. His work focuses on innovative treatments for pleural mesothelioma and lung cancer. He has also presented his work at major conferences, which highlights the importance of precision therapy for patients with limited options. Dr Dulloo strives to combine clinical excellence with compassionate care, ensuring the best possible outcomes for those he treats.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Sean Dulloo
Education & training
-
2004–2010 MD · Medicine and Surgery
-
2010–2014 Residency · Oncology
-
2014–2015 Fellowship · Subspecialty training
Career & appointments
-
2014-09–2015-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AXA Healthcare Liability · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 766 |
| Annual physical exam | 99395 | 2,840 |
| Vaccination administration | 90471 | 3,048 |
| Minor procedure (skin) | 17110 | 1,247 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 540.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 810.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 4
-
European registry analysis of Oncology outcomes
DOI: 10.5079/euroclin.2025.0 · PMID: 31711786 · cited by 182
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.1379/euroclin.2024.1 · PMID: 31228021 · cited by 84
-
European registry analysis of Oncology outcomes
DOI: 10.7284/euroclin.2023.2 · PMID: 36872636 · cited by 122
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2015
- national college of family doctors — Member · since 2015
- European Union of Medical Specialists (UEMS) — Member · since 2015
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · sean.dulloo@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
